These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28324283)

  • 1. Prognostic Value of Computed Tomography: Measured Parameters of Body Composition in Primary Operable Gastrointestinal Cancers.
    Black D; Mackay C; Ramsay G; Hamoodi Z; Nanthakumaran S; Park KGM; Loudon MA; Richards CH
    Ann Surg Oncol; 2017 Aug; 24(8):2241-2251. PubMed ID: 28324283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of body composition in patients with digestive tract cancers: A prospective cohort study of 8,267 adults from China.
    Han J; Liu X; Wang J; Tang M; Xu J; Tan S; Liu X; Wu G
    Clin Nutr ESPEN; 2024 Aug; 62():192-198. PubMed ID: 38901941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage disease.
    Shirdel M; Andersson F; Myte R; Axelsson J; Rutegård M; Blomqvist L; Riklund K; van Guelpen B; Palmqvist R; Gylling B
    Acta Oncol; 2020 Jul; 59(7):799-808. PubMed ID: 32228271
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
    Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
    Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Muscle and Adipose Tissue on Long-term Survival in Patients With Stage I to III Colorectal Cancer.
    Hopkins JJ; Reif RL; Bigam DL; Baracos VE; Eurich DT; Sawyer MB
    Dis Colon Rectum; 2019 May; 62(5):549-560. PubMed ID: 30789442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of computed tomography associated body composition measurement changes in metastatic colorectal cancer patients.
    Sevgilioglu ZE; Evrimler S; Iscan G; Kayikcioglu E; Sengul SS; Cetin B
    Acta Radiol; 2023 Nov; 64(11):2849-2857. PubMed ID: 37661639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial.
    Park HS; Kim HS; Beom SH; Rha SY; Chung HC; Kim JH; Chun YJ; Lee SW; Choe EA; Heo SJ; Noh SH; Hyung WJ; Cheong JH; Kim HI; Son T; Lim JS; Baek SE; Jung M
    Ann Surg Oncol; 2018 Oct; 25(11):3222-3230. PubMed ID: 30051367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial differences in body composition and survival among older adults with gastrointestinal malignancies.
    Aleixo GFP; Hess DL; Fowler ME; Giri S; Williams GR
    J Geriatr Oncol; 2024 May; 15(4):101747. PubMed ID: 38513310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer.
    Tamandl D; Paireder M; Asari R; Baltzer PA; Schoppmann SF; Ba-Ssalamah A
    Eur Radiol; 2016 May; 26(5):1359-67. PubMed ID: 26334504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
    Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
    J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenia is highly prevalent in patients undergoing surgery for gastric cancer but not associated with worse outcomes.
    Tegels JJ; van Vugt JL; Reisinger KW; Hulsewé KW; Hoofwijk AG; Derikx JP; Stoot JH
    J Surg Oncol; 2015 Sep; 112(4):403-7. PubMed ID: 26331988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT-based body composition analysis and pulmonary fat attenuation volume as biomarkers to predict overall survival in patients with non-specific interstitial pneumonia.
    Salhöfer L; Bonella F; Meetschen M; Umutlu L; Forsting M; Schaarschmidt BM; Opitz M; Beck N; Zensen S; Hosch R; Parmar V; Nensa F; Haubold J
    Eur Radiol Exp; 2024 Oct; 8(1):114. PubMed ID: 39400764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of body composition and survival in patients with locally advanced breast cancer: a historical cohort study.
    Pakdee W; Laohawiriyakamol T; Tanutit P; Laohawiriyakamol S; Liabsuetrakul T
    Acta Radiol; 2024 Jun; 65(6):575-587. PubMed ID: 38591936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
    Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
    BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed tomography-quantified body composition predicts short-term outcomes after gastrectomy in gastric cancer.
    Zhang Y; Wang JP; Wang XL; Tian H; Gao TT; Tang LM; Tian F; Wang JW; Zheng HJ; Zhang L; Gao XJ; Li GL; Wang XY
    Curr Oncol; 2018 Oct; 25(5):e411-e422. PubMed ID: 30464692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous adiposity is an independent predictor of mortality in cancer patients.
    Ebadi M; Martin L; Ghosh S; Field CJ; Lehner R; Baracos VE; Mazurak VC
    Br J Cancer; 2017 Jun; 117(1):148-155. PubMed ID: 28588319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors.
    Franzoi MA; Vandeputte C; Eiger D; Caparica R; Brandão M; De Angelis C; Hendlisz A; Awada A; Piccart M; de Azambuja E
    Breast Cancer Res Treat; 2020 May; 181(1):199-209. PubMed ID: 32246377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
    Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
    Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
    Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenia is a Negative Prognostic Factor After Curative Resection of Colorectal Cancer.
    Miyamoto Y; Baba Y; Sakamoto Y; Ohuchi M; Tokunaga R; Kurashige J; Hiyoshi Y; Iwagami S; Yoshida N; Yoshida M; Watanabe M; Baba H
    Ann Surg Oncol; 2015 Aug; 22(8):2663-8. PubMed ID: 25564158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.